Steward Partners Investment Advisory’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.93K | Hold |
61
| – | – | ﹤0.01% | 3362 |
|
|
2025
Q1 | $6.41K | Buy |
+61
| New | +$6.41K | ﹤0.01% | 3295 |
|
|
2022
Q4 | – | Sell |
-160
| Closed | -$9K | – | 3425 |
|
|
2022
Q3 | $9K | Hold |
160
| – | – | ﹤0.01% | 2575 |
|
|
2022
Q2 | $9K | Buy |
160
+104
| +186% | +$5.85K | ﹤0.01% | 2559 |
|
|
2022
Q1 | $4K | Sell |
56
-1,069
| -95% | -$76.4K | ﹤0.01% | 2961 |
|
|
2021
Q4 | $108K | Buy |
1,125
+25
| +2% | +$2.4K | ﹤0.01% | 1566 |
|
|
2021
Q3 | $96K | Buy |
1,100
+125
| +13% | +$10.9K | ﹤0.01% | 1569 |
|
|
2021
Q2 | $80K | Buy |
975
+598
| +159% | +$49.1K | ﹤0.01% | 2551 |
|
|
2021
Q1 | $35.8K | Buy |
377
+186
| +97% | +$17.7K | ﹤0.01% | 2165 |
|
|
2020
Q4 | $12K | Hold |
191
| – | – | ﹤0.01% | 2241 |
|
|
2020
Q3 | $11K | Hold |
191
| – | – | ﹤0.01% | 2102 |
|
|
2020
Q2 | $13K | Hold |
191
| – | – | ﹤0.01% | 1935 |
|
|
2020
Q1 | $8K | Sell |
191
-1
| -0.5% | -$42 | ﹤0.01% | 1938 |
|
|
2019
Q4 | $12K | Buy |
192
+1
| +0.5% | +$63 | ﹤0.01% | 1953 |
|
|
2019
Q3 | $11K | Buy |
191
+56
| +41% | +$3.23K | ﹤0.01% | 1953 |
|
|
2019
Q2 | $9K | Buy |
+135
| New | +$9K | ﹤0.01% | 2030 |
|
|
2018
Q4 | – | Sell |
-231
| Closed | -$40K | – | 1543 |
|
|
2018
Q3 | $40K | Buy |
231
+96
| +71% | +$16.6K | ﹤0.01% | 1283 |
|
|
2018
Q2 | $17K | Hold |
135
| – | – | ﹤0.01% | 1532 |
|
|
2018
Q1 | $13K | Buy |
+135
| New | +$13K | ﹤0.01% | 1486 |
|
|
2017
Q3 | – | Sell |
-48
| Closed | -$3K | – | 1722 |
|
|
2017
Q2 | $3K | Buy |
48
+8
| +20% | +$500 | ﹤0.01% | 1344 |
|
|
2017
Q1 | $2K | Buy |
+40
| New | +$2K | ﹤0.01% | 1316 |
|